Middle East & Africa Endomyocardial Biopsy Market Size & Outlook
Related Markets
MEA endomyocardial biopsy market highlights
- The MEA endomyocardial biopsy market generated a revenue of USD 24.0 million in 2024.
- The market is expected to grow at a CAGR of 7.9% from 2025 to 2030.
- In terms of segment, forceps was the largest revenue generating product in 2024.
- Forceps is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, Saudi Arabia is expected to register the highest CAGR from 2025 to 2030.
MEA data book summary
| Market revenue in 2024 | USD 24.0 million |
| Market revenue in 2030 | USD 37.8 million |
| Growth rate | 7.9% (CAGR from 2025 to 2030) |
| Largest segment | Forceps |
| Fastest growing segment | Forceps |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Forceps, Accessories |
| Key market players worldwide | Argon Medical Devices, Terumo Corp, Cardinal Health Inc, Scholten Surgical Instruments, Changzhou Lookmed Medical Instrument Co., Fehling Instruments |
Other key industry trends
- In terms of revenue, MEA region accounted for 6.6% of the global endomyocardial biopsy market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 123.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Endomyocardial Biopsy Market Scope
Endomyocardial Biopsy Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Fehling Instruments | View profile | 11-50 | Karlstein, Bayern, Germany, Europe | https://www.fehling-instruments.de |
| Changzhou Lookmed Medical Instrument Co. | View profile | 51-100 | Changzhou, Zhejiang, China, Asia | http://www.lookmedchina.com |
| Scholten Surgical Instruments | View profile | 1-10 | Lodi, California, United States, North America | https://www.novatome.com |
| Argon Medical Devices | View profile | 1001-5000 | Plano, Texas, United States, North America | http://www.argonmedical.com/ |
| Cardinal Health Inc | View profile | 48000 | 7000 Cardinal Place, Dublin, OH, United States, 43017 | https://www.cardinalhealth.com |
| Terumo Corp | View profile | 30207 | 2-44-1 Hatagaya, Shibuya-ku, Tokyo, Japan, 151-0072 | https://www.terumo.com |
Middle East & Africa endomyocardial biopsy market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to endomyocardial biopsy market will help companies and investors design strategic landscapes.
Forceps was the largest segment with a revenue share of 77.08% in 2024. Horizon Databook has segmented the Middle East & Africa endomyocardial biopsy market based on forceps, accessories covering the revenue growth of each sub-segment from 2018 to 2030.
Middle Eastern countries such as Saudi Arabia, Qatar, and the United Arab Emirates (UAE) are prospering economies. Advancements in the region's healthcare industry are expected to boost the demand for endomyocardial biopsy in this region.
The endomyocardial biopsy market in the Middle East and Africa is influenced by several factors, including the rising prevalence of cardiovascular diseases, advancements in healthcare infrastructure, and the availability of specialized medical facilities.
Heart diseases, such as myocarditis and cardiomyopathies, are a global health concern, and this trend is no different in the Middle East and Africa. The widespread occurrence of heart conditions plays a significant role in driving the demand for diagnostic procedures like endomyocardial biopsy.
Reasons to subscribe to Middle East & Africa endomyocardial biopsy market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa endomyocardial biopsy market databook
-
Our clientele includes a mix of endomyocardial biopsy market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa endomyocardial biopsy market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa endomyocardial biopsy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
MEA endomyocardial biopsy market size, by country, 2018-2030 (US$M)
Middle East & Africa Endomyocardial Biopsy Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
